Compare Abeona Therapeutics Inc (ABEO) vs Alliant Energy Corporation (LNT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Alliant Energy Corporation — how do they compare? Abeona Therapeutics Inc trades at $6.73 (market cap $373.32M), while Alliant Energy Corporation trades at $76.8 (market cap $20.06B). The key difference: Alliant Energy Corporation is far larger — about 53.7× Abeona Therapeutics Inc's market cap, and Alliant Energy Corporation pays a 2.69% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | LNT | |
|---|---|---|
Market Cap | $373.32M | $20.06B |
Sector | Health | Utilities |
52-Week High | $7.23 | $78.03 |
52-Week Low | $4.17 | $61.26 |
Enterprise Value | $228.22M | $31.78B |
Dividend Yield | — | 2.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
LNT trades at $77.65, down 0.49% on the day, with a bullish technical signal from moving averages and key resistance at $78. The company reported revenue of $4.36B in 2025 with net income of $810M, and recent quarters show mixed earnings performance against estimates. A $13.4B investment plan supports growth in data center demand and clean energy expansion, while analyst consensus is a Buy with a $75.67 price target.
LNT offers steady utility earnings growth and a dividend yield, but faces risks from rising debt levels and interest expenses. The stock's valuation multiples are above sector averages, requiring continued execution on capital investments to justify premium pricing amid competitive and regulatory pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →
